EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cordycepin Alleviates Acute Lung Injury by Targeting TAK1 to Inhibit MAPK and NF-κB Signaling Pathways

Junyan Wang, Kang Zhang, Jingyan Zhang, Zhiting Guo, Guowei Xu, Xiaowei Feng, Xiaoliang Chen, Shuqi Liu, Zhengzhong Luo, Lei Wang, Jianxi Li

Biomolecules · 2026

DOI: 10.3390/biom16091279 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2026. Verfasst von Junyan Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Traditional Chinese Veterinary Technology Innovation Center of Gansu Province, Key Laboratory of Veterinary Pharmaceutical Discovery, Ministry of Agr…. Hauptthemen laut MEDLINE: Acute Lung Injury, Deoxyadenosines, MAP Kinase Kinase Kinases, NF-kappa B. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China, The National Key Research and Development Program of China, China Agriculture Research System.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute lung injury (ALI) is a common clinical acute respiratory disorder driven primarily by a diffuse pulmonary inflammatory response. Cordycepin (COR) is a bioactive metabolite extracted from the fungus Cordyceps militaris, which possesses antioxidant and anti-inflammatory properties. However, its underlying molecular mechanism remains to be elucidated. This study evaluated the therapeutic effect of COR on ALI and the underlying molecular mechanisms. MH-S cells were primed with lipopolysaccharide (LPS) at 1 µg/mL for 24 h and then treated with varying doses of COR for an additional 24 h. WB and RT-qPCR analyses showed that COR inhibited the phosphorylation of TGF-β-activated kinase 1 (TAK1) as well as the key kinases in the MAPK and NF-κB pathways in LPS-induced MH-S cells, as evidenced by decreased TAK1, p38, JNK, IκB-α and P65 expression levels, as well as decreased TNF-α, IL-6, IL-1β, MAP3K7, MAPK8 and MAPK14 relative expression. Six-week-old BALB/c mice were intranasally instilled with LPS at 3 mg/kg, followed 24 h later by oral gavage administration of various concentrations of COR. The results showed that COR can effectively suppress the progression of pulmonary tissue injury; similarly, the expression levels of key proteins and inflammatory factors in the TAK1-MAPK and NF-κB signaling pathways were downregulated. In summary, COR exerts a therapeutic effect on ALI by directly targeting TAK1 to inhibit the activation of the MAPK and NF-κB signaling pathways and concurrently suppressing key inflammatory cytokines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Lung InjuryDeoxyadenosinesMAP Kinase Kinase KinasesNF-kappa BMAP Kinase Signaling SystemAnimalsMAP Kinase Kinase Kinase 7MiceLipopolysaccharidesMice, Inbred BALB CSignal TransductionMaleHumansCell Line

Stichwörter der Autor:innen

CordycepinLPSMAPK and NF-κB signaling pathwaysTAK1acute lung injury

Substanzen

MAP Kinase Kinase Kinase 7DeoxyadenosinesMAP Kinase Kinase KinasesNF-kappa BcordycepinLipopolysaccharides

Autor:innen und Institutionen

  • Traditional Chinese Veterinary Technology Innovation Center of Gansu Province, Key Laboratory of Veterinary Pharmaceutical Discovery, Ministry of Agriculture and Rural Affairs, Lanzhou Institute of Husbandry and Pharmac…
  • College of Veterinary Medicine, Gansu Agricultural University, Lanzhou 730000, China.
  • College of Veterinary Medicine, Hebei Agricultural University, Baoding 071000, China.

Förderung

  • the National Natural Science Foundation of China
  • The National Key Research and Development Program of China
  • China Agriculture Research System
  • the Innovation Project of Traditional Chinese Veterinary Medicine and Clinical Science

Zitieren

APA

Wang, J., Zhang, K., Zhang, J., Guo, Z., Xu, G., Feng, X., Chen, X., Liu, S., Luo, Z., Wang, L., & Li, J. (2026). Cordycepin Alleviates Acute Lung Injury by Targeting TAK1 to Inhibit MAPK and NF-κB Signaling Pathways. Biomolecules. https://doi.org/10.3390/biom16091279

Vancouver

Wang J, Zhang K, Zhang J, Guo Z, Xu G, Feng X, et al. Cordycepin Alleviates Acute Lung Injury by Targeting TAK1 to Inhibit MAPK and NF-κB Signaling Pathways. Biomolecules. 2026. doi:10.3390/biom16091279

BibTeX
@article{Wang2026,
  author = {Wang, Junyan and Zhang, Kang and Zhang, Jingyan and Guo, Zhiting and Xu, Guowei and Feng, Xiaowei and Chen, Xiaoliang and Liu, Shuqi and Luo, Zhengzhong and Wang, Lei and Li, Jianxi},
  title = {Cordycepin Alleviates Acute Lung Injury by Targeting TAK1 to Inhibit MAPK and NF-κB Signaling Pathways},
  journal = {Biomolecules},
  year = {2026},
  doi = {10.3390/biom16091279}
}
Kostenlos starten →